Article
Tumor microenvironment and CAR‐T cell immunotherapy in B‐cell lymphoma
14 Sept 2023
Abstract excerpt
Chimeric receptor antigen T cell (CAR-T cell) therapy has demonstrated effectiveness and therapeutic potential in the immunotherapy of hematological malignancies, representing a promising breakthrough in cancer treatment. Despite the efficacy of CAR-T cell therapy in B-cell lymphoma, response variability, resistance, and side effects remain persistent challenges. The tumor microenvironment (TME) plays an...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
